Comparative outcomes of primary, recurrent, and progressive high-risk non-muscle-invasive bladder cancer.
作者:
主题词
投药, 膀胱内(Administration, Intravesical);成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);抗肿瘤药(Antineoplastic Agents);卡介苗(BCG Vaccine);癌(Carcinoma);原位癌(Carcinoma in Situ);疾病恶化(Disease Progression);无病生存(Disease-Free Survival);英格兰(England);女(雌)性(Female);人类(Humans);Kaplan-Meiers评估(Kaplan-Meier Estimate);男(雄)性(Male);中年人(Middle Aged);多元分析(Multivariate Analysis);肿瘤侵润(Neoplasm Invasiveness);肿瘤复发, 局部(Neoplasm Recurrence, Local);比例危险度模型(Proportional Hazards Models);回顾性研究(Retrospective Studies);危险性评估(Risk Assessment);危险因素(Risk Factors);时间因素(Time Factors);治疗结果(Treatment Outcome);膀胱肿瘤(Urinary Bladder Neoplasms)
DOI
10.1016/j.eururo.2012.08.064
PMID
22985746
发布时间
2022-03-17
- 浏览27

European urology
145-54页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文